neurodudes » Blog Archive » Ampakine CX717 improves delayed match to sample performance

Ampakine CX717 improves delayed match to sample performance

Scientific Clearing House: Mind enhancing drugs

Apparently, CX717, an ampakine developed by Cortex Pharmaceuticals, shows some signs of preventing the cognitive impairment brought on by sleep deprivation. The original study in PLoS Biology (news & views) was done with monkeys.

This entry was posted on Monday, August 29th, 2005 at 1:21 am by Neville Sanjana and is filed under Memory systems, Neuropharmacology, Sleep. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

One Response to “Ampakine CX717 improves delayed match to sample performance”

neurodudes » Blog Archive » CX717: Preventing sleep deprivation trauma Says:
May 23rd, 2006 at 2:19 pm
[...] More information about the ampakine CX717 can be found here. We previously mentioned the delay match-to-sample performance improvement of monkeys on CX717. [...]

Leave a Reply

You must be logged in to post a comment.